Talis Biomedical Corp (33)
Browse by Contract Category
Contracts
-
Amended Supply Agreement, dated December 15, 2021, by and between the Registrant and thinXXS Microtechnology
(Filed With SEC on March 15, 2022)
-
Talis Biomedical Corporation Severance and Change in Control Plan and Amended Form of Participation Agreement thereunder
(Filed With SEC on March 15, 2022)
-
Offer Letter, dated December 8, 2021, by and between the Company and Robert Kelley
(Filed With SEC on December 9, 2021)
-
Form of Restricted Stock Unit Award Grant Notice and Award Agreement (Restricted Stock Unit Award) under the Talis Biomedical Corporation 2021 Inducement Plan
(Filed With SEC on November 15, 2021)
-
Lease Agreement, dated April 7, 2021, by and between the Registrant and SFF 3565 HAVEN, LLC
(Filed With SEC on May 13, 2021)
-
Talis Biomedical Corporation Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on March 15, 2022)
-
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the Talis Biomedical Corporation 2021 Equity Incentive Plan
(Filed With SEC on November 16, 2021)
-
Separation and Consulting Agreement by and between the Registrant and Brian Coe, dated August 30, 2021
(Filed With SEC on November 16, 2021)
-
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Talis Biomedical Corporation 2021 Inducement Plan
(Filed With SEC on November 15, 2021)
-
Talis Biomedical Corporation 2021 Inducement Plan
(Filed With SEC on November 15, 2021)
-
Offer Letter, dated November 1, 2021, by and between the Company and Brian Blaser
(Filed With SEC on November 15, 2021)
-
Registration Rights Agreement, dated March 26, 2021, by and among the Registrant, Baker Brothers Life Sciences L.P. and 667, L.P
(Filed With SEC on March 30, 2021)
-
Description of Securities
(Filed With SEC on March 30, 2021)
-
Talis Biomedical Corporation Severance and Change in Control Plan
(Filed With SEC on February 8, 2021)
-
Lease Agreement, dated January 20, 2021, by and between the Registrant and Westport Office Park, LLC
(Filed With SEC on February 8, 2021)
-
Lease, dated January 20, 2021, by and between the Registrant and Fulton Ogden Venture, LLC
(Filed With SEC on February 8, 2021)
-
Talis Biomedical Corporation Non-Employee Director Compensation Policy
(Filed With SEC on February 8, 2021)
-
Talis Biomedical Corporation 2021 Employee Stock Purchase Plan
(Filed With SEC on February 8, 2021)
-
Talis Biomedical Corporation 2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder
(Filed With SEC on February 8, 2021)
-
Form of Common Stock Certificate of the Registrant
(Filed With SEC on February 8, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on February 8, 2021)
-
Nominating Agreement, dated November 1, 2019, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P
(Filed With SEC on January 22, 2021)
-
Contract, dated July 30, 2020, by and between the Registrant and the National Institutes of Health
(Filed With SEC on January 22, 2021)
-
Supply Agreement, dated May 22, 2020, by and between the Registrant and thinXXS Microtechnology AG
(Filed With SEC on January 22, 2021)
-
Business Park Lease, dated December 14, 2015, by and between the Registrant and Facebook, Inc., as amended on April 4, 2018
(Filed With SEC on January 22, 2021)
-
Offer Letter, dated April 23, 2019, by and between the Registrant and Ramesh Ramakrishnan
(Filed With SEC on January 22, 2021)
-
Offer Letter, dated September 21, 2020, by and between the Registrant and Douglas Liu
(Filed With SEC on January 22, 2021)
-
Offer Letter, dated August 19, 2020, by and between the Registrant and Robert Kelley
(Filed With SEC on January 22, 2021)
-
Offer Letter, dated December 1, 2014, by and between the Registrant and Karen E. Flick
(Filed With SEC on January 22, 2021)
-
Offer Letter, dated April 3, 2020, by and between the Registrant and J. Roger Moody, Jr
(Filed With SEC on January 22, 2021)
-
Talis Biomedical Corporation 2013 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder, as amended
(Filed With SEC on January 22, 2021)
-
Form of Indemnity Agreement, by and between the Registrant and its directors and officers
(Filed With SEC on January 22, 2021)
-
Amended and Restated Investor Rights Agreement, dated October 30, 2020, by and among the Registrant and certain of its stockholders
(Filed With SEC on January 22, 2021)